A new role of Pro-73 of p47phox in the activation of neutrophil NADPH oxidase
Section snippets
Materials
Glutathione–Sepharose, CM-Sepharose FF, pGEX-6P, and Escherichia coli BL21 strain were purchased from Amersham Biosciences (Piscataway, NJ). Oligonucleotide primers for PCR and mutations were synthesized by the same manufacturer. BamHI and EcoRI were obtained from Toyobo (Tokyo, Japan). Thrombin and cytochrome c were purchased from Sigma–Aldrich (St. Louis, MO). Diisopropyl fluorophosphate was obtained from Wako Pure Chemicals (Osaka, Japan). GTP and FAD were purchased from Nacalai Tesque,
Requirement of PX domain for activation
Two groups reported that deletion of PX domain diminishes the ability of activation [18], [19]. However, as their deletions included additional 25 amino acid residues following the PX domain, actual role of the PX domain has not been clarified. Here, we made a p47phox fragment that lacks the exact region of the PX domain (assigned as ΔPX) and examined its ability to activate (Table 1). ΔPX showed a considerably lower ability to activate (33%). When the deletion was extended to residue 153
Discussion
A truncated form of p47phox (1–286) (p47N) is able to produce full activation of NADPH oxidase in a cell-free reconstitution system [19], [20], indicating that p47N contains all the domains essential for the activation. The p47N fragment possesses a PX domain and two SH3 domains with a connecting region in-between. The SH3 domains are thought to be involved in interaction with p22phox when unmasked. The PX domain is reportedly involved in negative regulation by interacting with one of the
Acknowledgements
This work was supported in part by a grant (13480297) for scientific research from the Ministry of Education, Science, Sports and Culture of Japan. We are grateful to Shuhei Kobayashi, Mamoru Tanaka, Yasuaki Komeima, Tetsutaro Kai, and Kyoji Watanabe for their excellent technical assistance and to Drs. Koichi Tanaka, Yaeta Endo, and Keiichi Kato (Department of Applied Chemistry, Ehime University) for their discussions and instruments. We are grateful to Drs. Chang-Hoon Han (Department of
References (48)
Blood
(1984)Biochim. Biophys. Acta
(1986)Free Radic. Biol. Med.
(1988)- et al.
Biochim. Biophys. Acta
(1994) Blood
(1999)- et al.
Biochim. Biophys. Acta
(2001) - et al.
Biochem. Biophys. Res. Commun.
(2000) - et al.
J. Biol. Chem.
(1994) - et al.
J. Biol. Chem.
(1994) - et al.
J. Biol. Chem.
(1996)
FEBS Lett.
J. Biol. Chem.
J. Biol. Chem.
J. Biol. Chem.
J. Biol. Chem.
Biochem. Biophys. Res. Commun.
J. Biol. Chem.
J. Biol. Chem.
Biochim. Biophys. Acta
J. Biol. Chem.
J. Biol. Chem.
J. Biol. Chem.
J. Biol. Chem.
J. Biol. Chem.
Cited by (7)
Atypical membrane-embedded phosphatidylinositol 3,4-bisphosphate (PI(3,4)P<inf>2</inf>)-binding site on p47<sup>phox</sup> phox homology (PX) domain revealed by NMR
2012, Journal of Biological ChemistryCitation Excerpt :Interestingly, our results can provide a rationale for the in vivo behaviors of two mutants, those of Pro-73 and Arg-70, that are within the presently identified C16-PI(3,4)P2-containing membrane-interacting interface. It has been reported that the mutation Pro-73 abrogates phosphoinositide recognition and interferes with the in vitro activity of NADPH oxidase (46), while the mutation Arg-70 prevents membrane translocation in HEK293 cells (47). Our experiments revealed that PA and soluble C4-PI(3,4)P2 competitively bind to the p47phox domain (Fig. 4).
Characterization and expression of NADPH oxidase in LPS-, poly(I:C)- and zymosan-stimulated trout (Oncorhynchus mykiss W.) macrophages
2009, Fish and Shellfish ImmunologyThe role of phosphoinositides and phosphorylation in regulation of NADPH oxidase
2004, Advances in Enzyme RegulationMolecular evolution of Phox-related regulatory subunits for NADPH oxidase enzymes
2007, BMC Evolutionary Biology